Baolingbao Biology Co Ltd (002286) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Baolingbao Biology Co Ltd (002286) has a cash flow conversion efficiency ratio of 0.061x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥134.96 Million ≈ $19.75 Million USD) by net assets (CN¥2.20 Billion ≈ $322.24 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 002286 company net worth for the company's overall valuation and market capitalisation.
Baolingbao Biology Co Ltd - Cash Flow Conversion Efficiency Trend (2006–2025)
This chart illustrates how Baolingbao Biology Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Baolingbao Biology Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Baolingbao Biology Co Ltd ranked by their cash flow conversion efficiency. Explore Baolingbao Biology Co Ltd earnings quality ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Testa Residencial SOCIMI S.A.
MC:YTST
|
N/A |
|
LandOcean Energy Services Co
SHE:300157
|
0.006x |
|
PTG Energy PCL
BK:PTG
|
0.112x |
|
Kangxin New Materials Co Ltd
SHG:600076
|
-0.009x |
|
Shanghai Jiaoda Onlly Co Ltd
SHG:600530
|
0.031x |
|
Symphony Limited
NSE:SYMPHONY
|
0.191x |
|
Shanghai Tianchen Co Ltd
SHG:600620
|
-0.040x |
|
Taiwan Navigation Co Ltd
TW:2617
|
0.046x |
Annual Cash Flow Conversion Efficiency for Baolingbao Biology Co Ltd (2006–2025)
The table below shows the annual cash flow conversion efficiency of Baolingbao Biology Co Ltd from 2006 to 2025. View Baolingbao Biology Co Ltd share price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥2.23 Billion ≈ $326.85 Million |
CN¥259.36 Million ≈ $37.95 Million |
0.116x | -4.69% |
| 2024-12-31 | CN¥2.04 Billion ≈ $298.74 Million |
CN¥248.72 Million ≈ $36.40 Million |
0.122x | -14.39% |
| 2023-12-31 | CN¥1.98 Billion ≈ $290.25 Million |
CN¥282.28 Million ≈ $41.31 Million |
0.142x | +825.49% |
| 2022-12-31 | CN¥2.00 Billion ≈ $293.30 Million |
CN¥30.82 Million ≈ $4.51 Million |
0.015x | -86.48% |
| 2021-12-31 | CN¥1.81 Billion ≈ $265.33 Million |
CN¥206.27 Million ≈ $30.18 Million |
0.114x | -54.34% |
| 2020-12-31 | CN¥1.60 Billion ≈ $234.04 Million |
CN¥398.46 Million ≈ $58.31 Million |
0.249x | +153.58% |
| 2019-12-31 | CN¥1.57 Billion ≈ $229.30 Million |
CN¥153.95 Million ≈ $22.53 Million |
0.098x | +13.86% |
| 2018-12-31 | CN¥1.54 Billion ≈ $225.64 Million |
CN¥133.05 Million ≈ $19.47 Million |
0.086x | +456.56% |
| 2017-12-31 | CN¥1.53 Billion ≈ $223.17 Million |
CN¥-36.91 Million ≈ $-5.40 Million |
-0.024x | -133.49% |
| 2016-12-31 | CN¥1.51 Billion ≈ $220.69 Million |
CN¥108.98 Million ≈ $15.95 Million |
0.072x | +37.85% |
| 2015-12-31 | CN¥1.48 Billion ≈ $216.29 Million |
CN¥77.49 Million ≈ $11.34 Million |
0.052x | -25.34% |
| 2014-12-31 | CN¥1.45 Billion ≈ $212.09 Million |
CN¥101.77 Million ≈ $14.89 Million |
0.070x | +17.74% |
| 2013-12-31 | CN¥1.44 Billion ≈ $210.03 Million |
CN¥85.60 Million ≈ $12.53 Million |
0.060x | -48.22% |
| 2012-12-31 | CN¥817.45 Million ≈ $119.62 Million |
CN¥94.15 Million ≈ $13.78 Million |
0.115x | -48.98% |
| 2011-12-31 | CN¥760.53 Million ≈ $111.29 Million |
CN¥171.70 Million ≈ $25.12 Million |
0.226x | +478.31% |
| 2010-12-31 | CN¥703.11 Million ≈ $102.89 Million |
CN¥27.45 Million ≈ $4.02 Million |
0.039x | -41.88% |
| 2009-12-31 | CN¥662.61 Million ≈ $96.96 Million |
CN¥44.51 Million ≈ $6.51 Million |
0.067x | -85.56% |
| 2008-12-31 | CN¥238.05 Million ≈ $34.83 Million |
CN¥110.77 Million ≈ $16.21 Million |
0.465x | +13.88% |
| 2007-12-31 | CN¥193.28 Million ≈ $28.28 Million |
CN¥78.98 Million ≈ $11.56 Million |
0.409x | +140.46% |
| 2006-12-31 | CN¥112.53 Million ≈ $16.47 Million |
CN¥19.12 Million ≈ $2.80 Million |
0.170x | -- |
About Baolingbao Biology Co Ltd
Baolingbao Biology Co.,Ltd., together with its subsidiaries, engages in the research, development, manufacturing, and sale of functional sugar in China and internationally. The company offers prebiotics, including galacto-oligosaccharides, isomaltooligosaccharides, fructooligosaccharides, and xylooligosaccharides; sugar alcohols and sources, such as erythritol, trehalose, crystallized fructose, a… Read more